Endo R&D: Building a Sustainable Pipeline

Endo R&D is strategically expanding the company's development pipeline by adding new projects through acquisitions and in-licensing, as well as by funding product life cycle management opportunities for approved products that support clear patient benefits.

With a focus on efficient investments through concentrating resources on lower risk, nearer-term, revenue-generating projects, we aim to maintain our specialty focus across a range of therapeutic areas that includes Pain, Urology, Men's Health, Orthopedics and Endocrinology.

About Endo


Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.

Visit Endo.com